Journey Medical Corp
NASDAQ:DERM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Journey Medical Corp
NASDAQ:DERM
|
US |
|
C
|
Corporate Office Properties Trust
F:WX7
|
US |
|
C
|
Comtech Telecommunications Corp
XMUN:CC6
|
US |
|
G
|
Green Brick Partners Inc
F:2G1
|
US |
|
Mesoblast Ltd
ASX:MSB
|
AU |
|
L
|
Lumentum Holdings Inc
SWB:LU2
|
US |
|
W
|
Walgreens Boots Alliance Inc
XMUN:W8A
|
US |
|
T
|
Take-Two Interactive Software Inc
F:TKE
|
US |
|
A
|
Anglo American PLC
XMUN:NGLB
|
UK |
|
Fugro NV
OTC:FUGRF
|
NL |
|
Bradespar SA
F:FXM
|
BR |
Wall St Price Targets
DERM Price Targets Summary
Journey Medical Corp
According to Wall Street analysts, the average 1-year price target for DERM is 13.77 USD with a low forecast of 12.12 USD and a high forecast of 16.8 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DERM's stock price target?
Price Target
13.77
USD
According to Wall Street analysts, the average 1-year price target for DERM is 13.77 USD with a low forecast of 12.12 USD and a high forecast of 16.8 USD.
What is the Revenue forecast for Journey Medical Corp?
Projected CAGR
48%
Over the last 5 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 3 years is 48%.
What is the Gross Profit forecast for Journey Medical Corp?
Projected CAGR
46%
Over the last 5 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 3 years is 46%.
